Key facts
- This page summarizes Janetta Trochimiuk's Form 3 filing for PDS Biotechnology Corp (PDSB).
- 0 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 18 Sep 2026, 16:34.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The option was granted on January 12, 2026, with 25% vesting on January 12, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Footnote F2
The option was granted on June 12, 2025, with 25% vesting on June 12, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Footnote F3
The option was granted on February 28, 2024, with 25% vesting on February 28, 2025 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Footnote F4
The option was granted on January 4, 2023, with 25% vesting on January 4, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Footnote F5
The options are fully vested and exercisable.